Microbot Medical (NASDAQ:MBOT) Stock Price Expected to Rise, HC Wainwright Analyst Says

Microbot Medical (NASDAQ:MBOT) had its target price increased by HC Wainwright from $7.00 to $9.00 in a report published on Friday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock.

Microbot Medical Stock Up 6.3 %

NASDAQ:MBOT opened at $2.03 on Friday. The firm has a market capitalization of $41.09 million, a price-to-earnings ratio of -2.54 and a beta of 1.46. Microbot Medical has a twelve month low of $0.82 and a twelve month high of $3.38. The stock’s 50 day moving average price is $1.31 and its two-hundred day moving average price is $1.09.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.